Bo Wei
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Health Informatics top 5%
Papers in
-
- Circular RNAs in diseases 9
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 6
-
- Gastric Cancer Management and Outcomes 39
- Metastasis and carcinoma case studies 9
- Co-authors
- Hongqing Xi (48 shared papers)Jianxin Cui (51 shared papers)Kecheng Zhang (37 shared papers)Xiaosong Wu (12 shared papers)Lin Chen (19 shared papers)Weisong Shen (14 shared papers)Jiyang Li (26 shared papers)Yunhe Gao (22 shared papers)
- Journals
- Oncotarget (7 papers)Biochemical and Biophysical Research Communications (5 papers)Surgical Endoscopy (5 papers)PLoS ONE (3 papers)Frontiers in Medicine (3 papers)
- Partner nations
- ChinaPhilippinesUnited States
In The Last Decade
Bo Wei
153 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 712
- Health Informatics 45
- Gastroenterology 155
- Pulmonary and Respiratory Medicine 682
- Oncology 576
Countries citing papers authored by Bo Wei
This map shows the geographic impact of Bo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wei more than expected).
Fields of papers citing papers by Bo Wei
This network shows the impact of papers produced by Bo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wei. The network helps show where Bo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 168 | |
| 2 | 2011 | 135 | |
| 3 | 2014 | 111 | |
| 4 | 2012 | 98 | |
| 5 | 2010 | 83 | |
| 6 | 2014 | 75 | |
| 7 | 2016 | 74 | |
| 8 | 2021 | 73 | |
| 9 | 2024 | 70 | |
| 10 | 2015 | 68 | |
| 11 | 2016 | 64 | |
| 12 | 2014 | 58 | |
| 13 | 2014 | 56 | |
| 14 | 2014 | 54 | |
| 15 | 2018 | 54 | |
| 16 | 2020 | 52 | |
| 17 | 2017 | 48 | |
| 18 | 2017 | 48 | |
| 19 | 2010 | 47 | |
| 20 | 2012 | 46 |
About Bo Wei
Bo Wei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 163 papers that have together received 3.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (39 papers), Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (11 papers), Metastasis and carcinoma case studies (9 papers), Circular RNAs in diseases (9 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (6 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). The work is most often cited by research in Cancer Research (712 citations), Health Informatics (45 citations), Gastroenterology (155 citations), Pulmonary and Respiratory Medicine (682 citations) and Oncology (576 citations). Bo Wei has collaborated with scholars based in China, Philippines and United States. Frequent co-authors include Hongqing Xi, Jianxin Cui, Kecheng Zhang, Xiaosong Wu, Lin Chen, Weisong Shen, Jiyang Li, Yunhe Gao, Wenquan Liang and Lin Chen. Their work appears in journals such as Oncotarget, Biochemical and Biophysical Research Communications, Surgical Endoscopy, PLoS ONE and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.